COMMUNIQUÉS West-GlobeNewswire

Y-mAbs Announces Data to be Presented at 2019 CTOS
30/08/2019
NEW YORK, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel [...]
HealthEquity Completes Acquisition of WageWorks
30/08/2019
Announces $80-100 Million Investment in Remarkable Service DRAPER, Utah, Aug. 30, 2019 (GLOBE NEWSWIRE) -- HealthEquity, Inc. (NASDAQ: HQY) ("HealthEquity" or the “Company”) today completed its acquisition of WageWorks [...]
Ultragenyx to Present at Upcoming Investor Conferences
30/08/2019
NOVATO, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare genetic diseases [...]
Biomerica Announces Fiscal Year End 2019 Financial Results
30/08/2019
IRVINE, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA ), a global provider of advanced medical products, today reported net sales for the fiscal year 2019 were $5,200,682 versus net sales of $5 [...]
Cytovance Biologics to Participate in Boston’s BioProcess International Convention
30/08/2019
OKLAHOMA CITY, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Cytovance ® Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the company will participate in the upcoming [...]
BBS Interim Report H1/2019
30/08/2019
BBS-Bioactive Bone Substitutes Plc (BBS) Interim Report January 1th – June 30th 2019 (unaudited) January-June shortly (comparison season 1-6/2018) Updates as required by the new Medical Device Regulation (MDR 2017/745) [...]
Novelion Therapeutics Provides Update Regarding Delisting from Nasdaq and Aegerion Bankruptcy Case
30/08/2019
VANCOUVER, British Columbia and CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Novelion Therapeutics Inc. (NASDAQ: NVLN) (“Novelion” or the “Company”), announced that, further to its press release dated August 21, [...]
Principia Biopharma Appoints Shawn Tomasello to Its Board of Directors
30/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
Orchard Therapeutics Further Strengthens Board of Directors with Appointment of John Curnutte, M.D., Ph.D.
30/08/2019
BOSTON and LONDON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life- [...]
The Lancet Infectious Diseases Publishes Results from Paratek’s Phase 3 Oral only Dosing Study of NUZYRA® (omadacycline) for Skin Infections
30/08/2019
Once-daily NUZYRA is non-inferior to twice-daily oral linezolid for the treatment of adults with ABSSSI, including MRSA; confirms efficacy and safety of oral-only formulation BOSTON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- [...]
Genocea to Present at September Healthcare Conferences
30/08/2019
CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that Chip Clark, president and [...]
Bhang Inc. Graduates to the OTCQX Best Market in U.S. and Announces OTC Ticker Symbol Change to “BHNGF”
30/08/2019
New market for trading to bring increased visibility and shareholder liquidity to Company Bhang will begin trading under OTC Ticker Symbol “BHNGF” MIAMI, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Bhang Inc. (" Bhang " or the " [...]
TCR² Therapeutics to Present at the BioCentury NewsMakers in the Biotech Industry Conference
30/08/2019
CAMBRIDGE, Mass., Aug. 30, 2019 (GLOBE NEWSWIRE) -- TCR² Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell therapies for patients suffering from [...]
Blueberries Medical Corp. Closes Over-Subscribed Private Placement
30/08/2019
Not for distribution into the United States or to U.S. newswire services TORONTO, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a [...]
Ambu A/S: Articles of Association
30/08/2019
Updated Articles of Association August 2019 Attachment complete AoA August 2019
Ambu A/S: Capital increase in connection with exercise of warrants issued
30/08/2019
In December 2013, Ambu A/S issued 2,000,000 warrants, and in December 2015 770,000 warrants, each warrant entitling the holder to subscribe for one Class B share with a nominal value of DKK 0.50. 52 individuals [...]
Myriad Genetics to Present at the 2019 Morgan Stanley Global Healthcare Conference
30/08/2019
SALT LAKE CITY, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled [...]
Akari Therapeutics’ Nomacopan Granted U.S. Orphan Drug Designation for Hematopoietic Stem Cell Transplantation-Associated Thrombotic Microangiopathy (HSCT-TMA)
30/08/2019
NEW YORK and LONDON, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), a biopharmaceutical company focused on innovative therapeutics to treat orphan autoimmune and inflammatory diseases where [...]
Lexicon Pharmaceuticals To Present At Upcoming Investor Conference
30/08/2019
THE WOODLANDS, Texas, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Jeffrey L. Wade, J.D., Executive Vice President, Corporate and Administrative Affairs and Chief [...]

Pages